Ara-290 (10mg*10vials)

ARA‑290 (also known as Cibinetide) is a synthetic peptide developed for its tissue‑protective and anti‑inflammatory properties. It is studied for potential benefits in reducing inflammation, protecting nerves, and supporting healing in stressed or damaged tissues.
This peptide works by selectively activating the innate repair receptor (IRR), which helps regulate the body’s response to injury and inflammation without stimulating red blood cell production like traditional erythropoietin (EPO) molecules. Through this mechanism, ARA‑290 may support nerve health, reduce pain, and improve cellular resilience in conditions involving inflammation or ischemic damage.
ARA‑290 is typically administered via injection in research or clinical trial settings. It is not widely approved for general medical use, and proper professional guidance and supervision are strongly recommended.